📰 Macula Associates News

Macula Associates News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Macula Associates. Real-time updates on events, politics, business and more.

Opthea highlights latest phase 3 trials for sozinibercept

April 12, 2024

The molecule is being evaluated in 2 phase 3 clinical trials for wet AMD and is administered via intravitreal injection in combination with standard-of-care anti–VEGF-A therapy.

United States University Of Nevada Charlesc Wykoff Arshadm Khanani Veerals Sheth Reno School Of Medicine

Source: ophthalmologytimes.com

Keeping A Watchful Eye: Safety Reports in Geographic Atrophy Landscape

December 26, 2023

A headline year for retina disease drug development concurrently brought about research and discussion into the safety outcomes of these new agents.

United States San Francisco Iapocec Apellis David Lally Kunzmannk Apellis Dilsher Dhoot

Source: hcplive.com

6 FDA Decisions Expected Before 2024

July 5, 2023

From a novel acne cream to a breakthrough depression drug, a half-dozen agent decisions are coming through in the coming 6 months.

New York United States Hilary Baldwin Arnold Silva Tenapanor Ardelyx Avacincaptad Pegol Iveric Bio

Source: hcplive.com

REGENXBIO to Host Virtual Investor Day Highlighting AAV Pipeline Programs with Upcoming Interim Trial Updates

June 27, 2023

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a virtual investor day on July 11, 2023. During the event, members of...

United States Veeral Sheth George Dickson Peter Kaiser Chris Brinzey Securities Exchange

Source: prnewswire.com